Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

Grove AI, pioneer in life science automation using agentic AI, today announced the formation of its inaugural Advisory Board.

“These findings reaffirm that the current Ocrevus IV 600 mg is optimally dosed to significantly slow disability progression,” ...

The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the ...

The European Commission has referred Eisai and Biogen’s application to an appeals committee. Elsewhere, Opthea warned of ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary ...

With counterfeit drugs making up 30% of global sales, regulators are tightening serialisation and labelling rules to secure ...

Havas Life Mumbai appoints Dorelle Kulkarni as managing director. She will lead strategic expansion and innovation in ...